REED ELIZABETH E bought TVTX
January 20, 2026 · Form 4 insider transaction
REED ELIZABETH E bought 10,000 shares of Travere Therapeutics, Inc. at $19.08 per share, a transaction worth $190.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$19.08
Total value
$190.8K
InsiderREED ELIZABETH E
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after100,270
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 392 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 28, 2025.